BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:As drug developers continue to utilize the expedited FDA regul
 atory pathway available for CBD\, alongside a growing interest in the the
 rapeutic benefits and regulatory approval of novel cannabinoids\, the can
 nabinoid drug development landscape is rapidly evolving. Additionally\, i
 nnovative preclinical candidates targeting CB1 and CB2 receptors are adva
 ncing through the pipeline\, as developers aim to secure regulatory appro
 val for treatments addressing weight management\, pain\, neurological con
 ditions\, and more.\n\nThe field continues to grow\, with both phytocanna
 binoid and synthetic drug candidates aspiring to achieve milestones like 
 those set by Epidiolex\, Marinol\, Syndros\, and Cesamet.\n\nJoin 60+ exp
 erts from discovery\, preclinical\, translational\, regulatory\, clinical
 \, and chemistry fields at the 7th CB1\, CB2\, and Cannabinoid Drug Devel
 opment Summit as they work to unlock the potential of CB1\, CB2\, and can
 nabinoid drugs for treating obesity\, pain\, inflammation\, CNS disorders
 \, and rare diseases.\n\nDate and Time: Monday\, 18 November 2024 at 09:0
 0 to Wednesday\, 20 November 2024 at 17:00\n
DTEND:20241120T170000
DTSTAMP:20260512T232942Z
DTSTART:20241118T090000
LOCATION:Wyndham Boston Beacon Hill\, 5 Blossom Street\, Boston\, Massachu
 setts\, 02114\,
SEQUENCE:0
SUMMARY:As drug developers continue to utilize the expedited FDA regulator
 y pathway available for CBD\, alongside a growing interest in the therape
 utic bene...
UID:01c3f56a-3f54-4acf-bc41-47d10ca1c277
END:VEVENT
END:VCALENDAR